Abiopharma

News list

📋 MICHAEL A STANKEY (Ex-Director) plans to sell 190K shares of OKTA, INC. (at $81.17 each, total $15.4M) Filed: Mar 23, 2026 | ID: 002929

Full text

News bot March 23, 2026, 9:43 p.m.
📋 Form 144 Filing: MICHAEL A STANKEY

Company: OKTA, INC.

Filing Date: 2026-03-23

Relationship: Former Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 190,000
- Price per Share: $81.17
- Total Value: $15,422,433.00
- Planned Sale Date: 2026-03-23
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38044
- Issuer Contact Phone: (888) 722-7871
- Issuer Address: 100 First Street, Suite 600, San Francisco, CA, 94105
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 169200461.0
- Number of Securities to be Sold: 1
- Signature: /s/ Michael A Stankey